RAN BioLinks’ Post

Canada has developed a #biomanufacturing and life sciences strategy which aims to strengthen Canada’s ability to promote a competitive, innovative, and sustainable life sciences and biomanufacturing sector as well as to respond to pandemics and future health emergencies. To do just that, the Government of Canada is dedicating $2.2 billion over seven years.   We are looking forward to the Swiss Biotech Day to continue building strong partnerships and collaboration between Canadian businesses and the Swiss biotech ecosystem. 🤝   Swiss Biotech Association Trade Commissioner Service | Service des délégués commerciaux BIOTECanada Innovation, Science and Economic Development Canada

Why are life sciences companies choosing the Edmonton Region? Take it from Ciba Health, a life sciences company that landed here in 2023! Ciba Health, a digital therapeutics and virtual healthcare company, expanded into Canada in July of 2023 by setting up its Canadian headquarters in the Edmonton Metro Region. 🇨🇦 According to Dr. Innocent Clement, CEO and Founder of Ciba Health, the company chose to expand to the Edmonton Region due to partnerships with key players like Alberta Innovates, Plug and Play Tech Center Alberta, and Edmonton Global. 🤝 The Region’s local talent was another major draw, with a 45% growth in tech jobs from 2017 to 2022. 💼👩💻 Curious to learn more about Ciba Health’s expansion and future plans? 🔍 Click here to read the full case study: https://lnkd.in/gWsqdNwX

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮 💼    As we bid farewell to BIO-Europe Spring 2024, let's take a moment to reflect on the lively atmosphere and collaborative spirit that filled the event's halls.    ✨ Facts & Figures ✨    🤝 ~120,000 meeting requests  🤝 ~20,000 meetings  🏢 1,947 companies represented  👥 3,452 delegates attended  💌 MONIPOL prepared ~280 meeting requests and had 25 meetings    These numbers speak volumes about the energy and collaboration present at the event. We were fortunate to connect with many companies interested in exploring our services: throughout the event, we made it a priority to prepare thoroughly and understand our potential clients' needs. This emphasis on research and client-centricity beforehand ensured that meetings were not only productive but also truly beneficial for everyone involved 🤝    𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 𝐰𝐢𝐭𝐡 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐞𝐯𝐞𝐧𝐭? Don't worry! Contact us for follow-ups and learn more about how we can support your trials. Let's continue the conversation and explore exciting opportunities at the Virtual Partnering Event, held on 26-27 March 📅     A big thank you to everyone who made BIO-Europe Spring 2024 such a success. We are looking forward to connecting further and supporting innovative biotech pioneers.    Another big thanks to EBD Group for providing a platform to connect the global BioPharma community. We are pleased to have played a part in fostering this vibrant atmosphere.      #BIOEuropeSpring #Biotech #CRO #clinicaltrials #clinicaldevelopment 

James Sabry ‘s Question for Biopharma Leaders: Is Your Deal-Making Approach Future-Ready? https://lnkd.in/gEPdyzmp James Sabry highlights a critical shift in biopharma: partnerships are moving beyond transactions to value-driven collaborations with lasting impact. For industry leaders, this means rethinking strategies to focus on transformative therapies and sustainable innovation. Is your team ready to adapt? This analysis could help you build a new roadmap? Insights and analysis from Simone Fishburn 🎗️ : https://lnkd.in/gEPdyzmp BioCentury Inc. BioMarin Pharmaceutical Inc. #biotech #deals

I’m excited to be attending Bio-Europe from November 4-6 in Stockholm. Looking forward to reconnecting with our valued partners and exploring new opportunities for collaboration. Feel free to reach out if you’ll be there as well – I’d love to meet and discuss how we can work together! #BioEurope #Networking #BusinessDevelopment #Collaboration #Partnerships #LifeSciences #PharmaIndustry"

Come meet us at booth 47 to discuss your bioprocess development and manufacturing needs!

The morning after the night before. No, not that one. But the #BIOEurope drinks reception in Stockholm's Nacka Strand Bilfabriken. Thanks again to the excellent EBD Group for hosting another great event. Essential to connect with colleagues and industry partners, and also stay abreast of the latest biopharma thinking in the content sessions. I'm grateful to be able to share the perspectives from Citeline and Evaluate Ltd as part of Monday's industry trends session alongside Isma Hachi, PhD from IQVIA. The ecosystem is navigating funding and productivity challenges to continue to progress a healthy pipeline, although this cannot be taken for granted. Partnerships and deal-making is fundamental to this, but comments from the audience suggest that greater investment and autonomy for the biotech innovators would be welcome. Meanwhile, pharma companies backed by extensive scouting networks and large revenue streams continue to cherry pick treatments with the highest potential. Looking ahead, I'll be discussing some of the major conference themes in a webinar next Thursday (November 14) alongside the in-demand Melanie Senior, who moderated a handful of her own sessions at BIO-Europe. Please do join us - registration is free and available here: https://lnkd.in/e5K5FgqX

Did you know? Jarosław Kasprowicz, PhD, MBA, Head of Clinical Operations at Clinmark, who will be representing us at the upcoming Bio Convention in San Diego, boasts over 12 years of extensive expertise in clinical trials setup, monitoring, and management across diverse therapeutic fields. With his wealth of experience, he's ready to explore collaborations and discuss how Clinmark can elevate your research. Don't miss this opportunity to connect and schedule a meeting with him! #Clinmark #BioConvention #SanDiego #ClinicalResearch #CebioForum #PolishTradeandInvestmentAgncy

Yesterday, Roche Danmark together with Danish Chamber of Commerce (Dansk Erhverv) co-hosted the event "Exploring European Life Science Competitiveness," bringing all of Roche’s General Managers in Europe together with key external stakeholders from Denmark to discuss how we can strengthen and maintain Europe's #competitiveness in the life science sector. The Danish Ministry of Business and Lif - Lægemiddelindustriforeningen each shared learnings and insights into Denmark's efforts to become a global leading life science nation and also how they prepare for the upcoming Danish EU presidency. We also had the opportunity to engage in fruitful discussions about the future of public private collaboration between industry and the healthcare sector to address capacity challenges and create societal value. A few key takeaways: → The life sciences sector is a crucial strategic asset for Europe, delivering innovations vital for the health and benefit of EU citizens and societies. However, we need to address challenges around access to new innovation and attracting R&D. Europe must become more attractive for investments as other global regions. → Unlocking the full potential of tomorrow’s resilient healthcare system requires prioritizing long-term value and impact from innovations, with data-driven decision-making as the key. Translating new knowledge and data into actionable strategies is essential for advancing our healthcare systems. Thanks to all participants for a great afternoon. #Roche #EU #Draghi #dklifescience #lifescience #pharma EFPIA - European Federation of Pharmaceutical Industries and Associations WifOR Institute

🎬 Learn more about BioAlps - Life Sciences Cluster 🇨🇭 in the latest instalment of Greater Geneva Bern area (GGBa) "WHAT IS" series!